OpenAlex
PricingAboutJobs
Log inGet started
Work

Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study

HTML

Year: 2016
Type: article
Source: Osteoporosis International
DOI: 10.1007/s00198-016-3503-0
Authors: R. Rizzoli, C.-L. Benhamou, J. Halse, P. D. Miller, I. R. Reid, J. A. Rodríguez Portales, C. DaSilva, R. Kroon, N. Verbruggen, A. T. Leung, D. Gurner
Institutions: University Hospital of Geneva, Colorado Center for Bone Research, University of Auckland, Pontificia Universidad Católica de Chile, Merck & Co., Inc., Rahway, NJ, USA (United States), MSD (Netherlands), MSD (Belgium)
Language: English

Topic: Bone health and osteoporosis research
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: odanacatib, cathepsin K inhibitors, postmenopausal osteoporosis, osteopenia, long-term treatment safety, bone mineral density, bone resorption markers, bone formation markers, lumbar spine, hip, osteonecrosis of the jaw, osteoporosis
SDG: Good health and well-being

Open Access status: green
OpenAlex ID: W2287074011
FWCI: 5.798
Cites: 31
Cited by: 40
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security